Pharming Group N.V. (PHAR)

Pharming Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,360	650	763	756	572	993
Market Cap Growth	112.92%	-14.84%	0.93%	32.18%	-42.41%	-10.20%
Enterprise Value	1,325	608	728	702	554	963
Last Close Price	19.93	10.06	11.43	11.03	8.94	15.20
PE Ratio	3561.45	-	-	55.27	35.75	26.30
PS Ratio	3.76	2.19	3.11	3.68	2.88	4.68
PB Ratio	5.14	2.94	3.49	3.69	2.96	5.41
P/TBV Ratio	10.49	4.06	5.17	5.82	5.23	10.47
P/FCF Ratio	25.80	-	-	35.85	21.10	12.57
P/OCF Ratio	25.51	-	-	33.66	15.11	11.87
EV/Sales Ratio	3.66	2.05	2.97	3.41	2.78	4.54
EV/EBITDA Ratio	27.66	188.69	-	40.97	18.22	11.66
EV/EBIT Ratio	31.96	-	-	67.70	23.07	12.62
EV/FCF Ratio	25.14	-	-	33.29	20.43	12.19
Debt / Equity Ratio	0.50	0.51	0.78	0.82	0.84	0.88
Debt / EBITDA Ratio	2.55	17.02	-	8.46	4.88	1.92
Debt / FCF Ratio	2.48	-	-	7.91	5.97	2.05
Asset Turnover	0.81	0.69	0.55	0.50	0.49	0.63
Inventory Turnover	0.57	0.63	0.51	0.50	0.87	1.26
Quick Ratio	2.39	2.96	3.28	3.90	4.69	3.09
Current Ratio	3.16	3.77	4.06	4.65	5.33	3.43
Return on Equity (ROE)	0.03%	-5.38%	-4.98%	6.88%	8.50%	25.09%
Return on Assets (ROA)	5.76%	-0.52%	-3.06%	1.57%	3.68%	14.13%
Return on Invested Capital (ROIC)	0.08%	-2.10%	-12.76%	5.79%	10.98%	54.07%
Return on Capital Employed (ROCE)	10.70%	-1.10%	-5.70%	2.80%	6.80%	22.30%
Earnings Yield	0.03%	-1.82%	-1.38%	1.81%	2.80%	3.80%
FCF Yield	3.88%	-0.40%	-2.46%	2.79%	4.74%	7.95%
Buyback Yield / Dilution	2.65%	-2.18%	7.09%	-0.85%	-2.70%	-1.37%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q